
Argos Therapeutics
http://www.argostherapeutics.com/Argos is focused on the treatment of metastatic cancers and chronic infections using a proprietary platform technology that stimulates immune cells with messenger RNA. The company’s lead product is for the personalized treatment of advanced renal cell carcinoma and is in phase III clinical development. A second product for therapeutic vaccination in HIV is in phase II development. Argos has also developed an interferon-neutralizing antibody for systemic lupus and has developed a CD83 Soluble Protein for Transplant Rejection/ Autoimmune Disorders in late preclinical development. Argos is listed on Nasdaq and traded under the symbol ARGS.
Location: United States, Durham
Total raised: $301.4M
Investors 2
Date | Name | Website |
- | Forbion | forbion.co... |
- | Signet Hea... | signetheal... |
Funding Rounds 7
Date | Series | Amount | Investors | Deal News |
11.03.2016 | - | $60M | - | - |
20.11.2013 | Series E | $17.5M | - | - |
26.08.2013 | Series E | $42.5M | - | - |
24.04.2012 | Series D | $25M | - | - |
29.07.2011 | IPO | $86M | - | - |
24.11.2008 | Series C | $35.2M | - | - |
23.04.2008 | Series C | $35.2M | - | - |
Mentions in press and media 20
Date | Title | Description | Category | Author | Source |
10.01.2018 | Lummy Inve... | Argos Therapeutics Inc., biote... | - | - | citybizlis... |
29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |
11.03.2016 | Argos Ther... | Argos Therapeutics, Inc. (Nasd... | - | - | forbion.co... |
20.11.2013 | Argos Ther... | Argos Therapeutics Inc., a Dur... | Uncategori... | - | finsmes.co... |
20.11.2013 | Argos Ther... | Argos Therapeutics Inc., a bio... | - | - | forbion.co... |
30.08.2013 | Argos Ther... | Argos Therapeutics Inc., a bio... | - | - | forbion.co... |
28.08.2013 | Argos Ther... | Argos Therapeutics Inc., a Dur... | funding U... | - | finsmes.co... |
26.08.2013 | Argos Ther... | Argos Therapeutics Inc., a bio... | - | - | forbion.co... |
15.01.2013 | Personaliz... | CEO Jeff Abbey told MedCity Ne... | - | - | medcitynew... |
08.06.2012 | Experiment... | Argos had planned to support i... | - | - | medcitynew... |
Show more